Literature DB >> 19749205

Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes.

M Saint-Pierre-Chazalet1, M Ben Brahim, L Le Moyec, C Bories, M Rakotomanga, P M Loiseau.   

Abstract

OBJECTIVES: This study focuses on the importance of sterols in the action of miltefosine (hexadecylphosphocholine, HePC) against Leishmania donovani.
METHODS: Plasma membranes of L. donovani promastigotes were depleted of sterol using methyl-beta-cyclodextrin (MCD) and cholesterol oxidase (CH-OX). Sterols were quantified and HePC susceptibility was assessed using the MTT test. A biomimetic model of the outer leaflet of a Leishmania plasma membrane was used to decipher the HePC-lipid interactions.
RESULTS: CH-OX, which is known to act more specifically on condensed membranes, therefore at the level of lipid rafts, gave a better extraction yield in HePC-resistant parasites, confirming the more rigid structure of their membranes than those of wild-type parasites. Sterol depletion was responsible for a 40% decrease in HePC susceptibility in both wild-type and HePC-resistant parasites. Sterol repletion of the sterol-depleted parasites restored HePC susceptibility. The biomimetic model of the outer leaflet of a Leishmania plasma membrane confirmed that condensed microdomains were able to incorporate higher quantities of HePC than fluid ones and this result was amplified when the sterol concentration was increased.
CONCLUSIONS: Sterol and lipid rafts probably play a significant role as an HePC reservoir providing a constant supply to the previously described transporter. In addition, (1)H NMR experiments suggested that HePC stimulated lipid trafficking in parasites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19749205     DOI: 10.1093/jac/dkp321

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

Authors:  Maya Berg; Raquel García-Hernández; Bart Cuypers; Manu Vanaerschot; José I Manzano; José A Poveda; José A Ferragut; Santiago Castanys; Jean-Claude Dujardin; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 2.  Amphotericin B membrane action: role for two types of ion channels in eliciting cell survival and lethal effects.

Authors:  B Eleazar Cohen
Journal:  J Membr Biol       Date:  2010-11-18       Impact factor: 1.843

3.  Drug combinations as effective anti-leishmanials against drug resistant Leishmania mexicana.

Authors:  Humera Ahmed; Charlotte R Curtis; Sara Tur-Gracia; Toluwanimi O Olatunji; Katharine C Carter; Roderick A M Williams
Journal:  RSC Med Chem       Date:  2020-07-02

4.  Attenuation of Leishmania infantum chagasi metacyclic promastigotes by sterol depletion.

Authors:  Chaoqun Yao; Upasna Gaur Dixit; Jason H Barker; Lynn M Teesch; Laurie Love-Homan; John E Donelson; Mary E Wilson
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

5.  Metabolic variation during development in culture of Leishmania donovani promastigotes.

Authors:  Ana Marta Silva; Anabela Cordeiro-da-Silva; Graham H Coombs
Journal:  PLoS Negl Trop Dis       Date:  2011-12-20

6.  Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.

Authors:  Janny A Villa-Pulgarín; Consuelo Gajate; Javier Botet; Alberto Jimenez; Nicole Justies; Rubén E Varela-M; Álvaro Cuesta-Marbán; Ingrid Müller; Manuel Modolell; José L Revuelta; Faustino Mollinedo
Journal:  PLoS Negl Trop Dis       Date:  2017-08-22

7.  Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine.

Authors:  Emily G Armitage; Amjed Q I Alqaisi; Joanna Godzien; Imanol Peña; Alison J Mbekeani; Vanesa Alonso-Herranz; Ángeles López-Gonzálvez; Julio Martín; Raquel Gabarro; Paul W Denny; Michael P Barrett; Coral Barbas
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

8.  Lipid profile of Trichinella papuae muscle-stage larvae.

Authors:  Suthee Mangmee; Poom Adisakwattana; Phornpimon Tipthara; Nattapon Simanon; Piengchan Sonthayanon; Onrapak Reamtong
Journal:  Sci Rep       Date:  2020-06-23       Impact factor: 4.379

9.  Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study.

Authors:  Thomas P C Dorlo; Anke E Kip; Brima M Younis; Sally J Ellis; Fabiana Alves; Jos H Beijnen; Simon Njenga; George Kirigi; Asrat Hailu; Joseph Olobo; Ahmed M Musa; Manica Balasegaram; Monique Wasunna; Mats O Karlsson; Eltahir A G Khalil
Journal:  J Antimicrob Chemother       Date:  2017-11-01       Impact factor: 5.790

10.  Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition.

Authors:  Dimitri Bulté; Lieselotte Van Bockstal; Laura Dirkx; Magali Van den Kerkhof; Carl De Trez; Jean-Pierre Timmermans; Sarah Hendrickx; Louis Maes; Guy Caljon
Journal:  PLoS Negl Trop Dis       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.